Patients' and health professionals' attitudes and perceptions towards the initiation of preventive drugs for primary prevention of cardiovascular disease: a systematic review of qualitative studies.
Qualitative research
antihypertensive drugs
cardiovascular disease
primary prevention
statins
Journal
BJGP open
ISSN: 2398-3795
Titre abrégé: BJGP Open
Pays: England
ID NLM: 101713531
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
10
02
2020
accepted:
06
03
2020
pubmed:
22
10
2020
medline:
22
10
2020
entrez:
21
10
2020
Statut:
epublish
Résumé
Statins and antihypertensive agents are recommended for primary prevention of cardiovascular disease (CVD), but they are not always prescribed to eligible patients. A systematic review of qualitative studies. To explore health professionals' and patients' attitudes towards cardiovascular preventive drugs. MEDLINE, Embase, PsychINFO, CINAHL, ASSIA, HMIC, Conference Proceedings Citation Index, and Open Grey were searched for studies of qualitative design without restrictions on date or language. Two reviewers performed study selection, data extraction, quality assessment, and thematic synthesis. In total, 2585 titles and abstracts were screened, yielding 27 studies, of which five met eligibility criteria on full text assessment. These included 62 patients and 47 health professionals. Five themes emerged about patient attitudes: questioning preventive drugs; perceived benefit and risks, such as improving quality of life; patient preferences; trust in health professional judgement; and family, friends, and media influences. Five themes emerged about health professional attitudes: addressing patient concerns and information; duty as a health professional to prescribe; uncertainty about preventive drug prescribing; recognising consequences of prescribing, such as unnecessary medicalisation; and personalised treatment. The attitudes of patients and health professionals regarding drug initiation for primary prevention reflect the complexity of the patient-health professional encounter in primary practice. For prescribing to be more adherent to guidelines, research should further investigate the patient-health professional relationship and the appropriate communication methods required when discussing drug initiation, specifically for primary prevention.
Sections du résumé
BACKGROUND
BACKGROUND
Statins and antihypertensive agents are recommended for primary prevention of cardiovascular disease (CVD), but they are not always prescribed to eligible patients.
DESIGN & SETTING
METHODS
A systematic review of qualitative studies.
AIM
OBJECTIVE
To explore health professionals' and patients' attitudes towards cardiovascular preventive drugs.
METHOD
METHODS
MEDLINE, Embase, PsychINFO, CINAHL, ASSIA, HMIC, Conference Proceedings Citation Index, and Open Grey were searched for studies of qualitative design without restrictions on date or language. Two reviewers performed study selection, data extraction, quality assessment, and thematic synthesis.
RESULTS
RESULTS
In total, 2585 titles and abstracts were screened, yielding 27 studies, of which five met eligibility criteria on full text assessment. These included 62 patients and 47 health professionals. Five themes emerged about patient attitudes: questioning preventive drugs; perceived benefit and risks, such as improving quality of life; patient preferences; trust in health professional judgement; and family, friends, and media influences. Five themes emerged about health professional attitudes: addressing patient concerns and information; duty as a health professional to prescribe; uncertainty about preventive drug prescribing; recognising consequences of prescribing, such as unnecessary medicalisation; and personalised treatment.
CONCLUSION
CONCLUSIONS
The attitudes of patients and health professionals regarding drug initiation for primary prevention reflect the complexity of the patient-health professional encounter in primary practice. For prescribing to be more adherent to guidelines, research should further investigate the patient-health professional relationship and the appropriate communication methods required when discussing drug initiation, specifically for primary prevention.
Identifiants
pubmed: 33082157
pii: bjgpopen20X101087
doi: 10.3399/bjgpopen20X101087
pmc: PMC7880193
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright © 2020, The Authors.
Références
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Am Heart Assoc. 2016 Oct 22;5(10):
pubmed: 27792661
Br J Gen Pract. 2015 Aug;65(637):e538-44
pubmed: 26212850
Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004816
pubmed: 23440795
Br J Gen Pract. 2015 Jul;65(636):e447-53
pubmed: 26077268
BMJ Open. 2019 Apr 11;9(4):e025587
pubmed: 30975677
Qual Health Res. 2012 Oct;22(10):1435-43
pubmed: 22829486
BMC Fam Pract. 2009 Apr 21;10:24
pubmed: 19383116
PLoS One. 2014 Mar 11;9(3):e90941
pubmed: 24618683
Br J Gen Pract. 2017 Dec;67(665):e881-e887
pubmed: 29061715
Arch Intern Med. 2006 Nov 27;166(21):2307-13
pubmed: 17130382
JAMA Intern Med. 2018 Jan 1;178(1):28-36
pubmed: 29131895
Br J Gen Pract. 2018 Jun;68(671):e408-e419
pubmed: 29784867
Health Aff (Millwood). 2004 Jul-Aug;23(4):124-32
pubmed: 15318572
Stroke. 2018 Mar;49(3):682-687
pubmed: 29440471
Br J Gen Pract. 2003 Sep;53(494):684-9
pubmed: 15103875
BMC Med Res Methodol. 2012 Nov 27;12:181
pubmed: 23185978
Public Health. 2013 Oct;127(10):958-60
pubmed: 24070696
Curr Opin Cardiol. 2012 Sep;27(5):533-41
pubmed: 22820103
BMC Fam Pract. 2011 Jun 26;12:59
pubmed: 21703010
Bull World Health Organ. 2014 Jan 1;92(1):10-19C
pubmed: 24391296
BMC Fam Pract. 2014 Jul 02;15:130
pubmed: 24989986
BMJ Open. 2013 Mar 25;3(3):
pubmed: 23533217
J Hum Hypertens. 2007 Feb;21(2):99-106
pubmed: 17136106
BMC Med Res Methodol. 2008 Jul 10;8:45
pubmed: 18616818
JAMA Cardiol. 2016 Jun 1;1(3):341-9
pubmed: 27438118
J Gen Intern Med. 2000 Jul;15(7):509-13
pubmed: 10940139
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
J Gen Intern Med. 2015 Jun;30(6):768-76
pubmed: 25650264
BMJ Open. 2018 Nov 1;8(11):e021137
pubmed: 30389756
Patient Educ Couns. 2012 Oct;89(1):57-62
pubmed: 22770676
Int J Family Med. 2012;2012:612572
pubmed: 23213524
PLoS One. 2013 Jul 26;8(7):e67611
pubmed: 23922649
J Gen Intern Med. 2014 May;29(5):723-31
pubmed: 24493322